WASHINGTON — Advisers to the Food and Drug Administration say trouble-prone medical products widely used to surgically repair women's pelvic problems need stringent testing for safety and effectiveness.
Don't miss these Health stories
More women opting for preventive mastectomy - but should they be?
Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.
- Larry Page's damaged vocal cords: Treatment comes with trade-offs
- Report questioning salt guidelines riles heart experts
- CDC: 2012 was deadliest year for West Nile in US
- What stresses moms most? Themselves, survey says
- More women opting for preventive mastectomy - but should they be?
It's another case of a problem that wasn't flagged until patients got hurt.
The advisory panel on Thursday urged the FDA to reclassify plastic surgical mesh used to repair pelvic collapse. The consensus recommendation means that, if the FDA agrees, manufacturers would be required to prove the safety and effectiveness of the products.
Consumer groups want a recall, but medical device makers say mesh offers advantages, and the rate of serious complications is low. The FDA said in July it had underestimated the risks, which include pain, bleeding and infection.
The agency often follows the recommendations of its advisers.
Copyright 2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.